Terug
Dagbereik
€ 3,85
€ 5,50
52-Weeksbereik
€ 3,17
€ 5,50
Volume
2.643
50D / 200D Gem.
€ 4,46
/
€ 4,48
Vorige Slotkoers
€ 4,26
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 2,6 | 0,3 |
| P/B | 0,3 | 2,9 |
| ROE % | 9,7 | 3,7 |
| Net Margin % | 15,5 | 3,8 |
| Rev Growth 5Y % | 6,7 | 10,0 |
| D/E | 0,8 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 0,00
€ 0,00 – € 0,00
|
10 B | 0 |
| FY2026 |
€ 0,00
€ 0,00 – € 0,00
|
9,2 B | 0 |
Belangrijkste Punten
Revenue grew 6,71% annually over 5 years — modest growth
Earnings declined -10,86% over the past year
Net margin of 15,53% shows strong profitability
Generating 1,78B in free cash flow
P/E of 2,64 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 3,26%
Groei
Revenue Growth (5Y)
6,71%
Revenue (1Y)3,45%
Earnings (1Y)-10,86%
FCF Growth (3Y)5,88%
Kwaliteit
Return on Equity
9,71%
ROIC5,96%
Net Margin15,53%
Op. Margin22,57%
Veiligheid
Debt / Equity
0,75
Current Ratio1,47
Interest Coverage1,67
Waardering
P/E Ratio
2,64
P/B Ratio0,25
EV/EBITDA6,24
Dividend Yield0,04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3,45% | Revenue Growth (3Y) | -1,37% |
| Earnings Growth (1Y) | -10,86% | Earnings Growth (3Y) | -14,83% |
| Revenue Growth (5Y) | 6,71% | Earnings Growth (5Y) | -2,64% |
| Profitability | |||
| Revenue (TTM) | 7,70B | Net Income (TTM) | 1,20B |
| ROE | 9,71% | ROA | 4,75% |
| Gross Margin | 59,04% | Operating Margin | 22,57% |
| Net Margin | 15,53% | Free Cash Flow (TTM) | 1,78B |
| ROIC | 5,96% | FCF Growth (3Y) | 5,88% |
| Safety | |||
| Debt / Equity | 0,75 | Current Ratio | 1,47 |
| Interest Coverage | 1,67 | Dividend Yield | 0,04% |
| Valuation | |||
| P/E Ratio | 2,64 | P/B Ratio | 0,25 |
| P/S Ratio | 0,41 | PEG Ratio | -1,11 |
| EV/EBITDA | 6,24 | Dividend Yield | 0,04% |
| Market Cap | 3,15B | Enterprise Value | 10,84B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7,70B | 7,44B | 7,91B | 7,55B | 5,94B |
| Net Income | 1,20B | 1,34B | 1,65B | 1,70B | 1,33B |
| EPS (Diluted) | 1,89 | 2,10 | 2,58 | 2,65 | 2,08 |
| Gross Profit | 4,55B | 4,38B | 5,00B | 4,76B | 3,80B |
| Operating Income | 1,74B | 1,80B | 2,29B | 2,64B | 2,04B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 25,16B | 24,56B | 24,51B | 23,76B | 19,82B |
| Total Liabilities | 12,63B | 12,46B | 12,99B | 13,10B | 9,98B |
| Shareholders' Equity | 12,52B | 12,10B | 11,50B | 10,65B | 9,83B |
| Total Debt | 9,34B | 9,40B | 9,96B | 9,68B | 7,41B |
| Cash & Equivalents | 1,65B | 1,74B | 2,58B | 2,86B | 2,29B |
| Current Assets | 6,05B | 6,68B | 8,08B | 8,53B | 6,49B |
| Current Liabilities | 4,11B | 3,94B | 4,64B | 5,23B | 2,78B |